www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
administrative expenses for the three months period ended 31 March 2018 and 2019 at THB 34.11 million and THB 40.14 million respectively. This equals to a surge of 17.68 % in administrative expenses year on year
& expenses (net of tax) from the comparing quarters, the normalized net profit would be approximately THB 72.8 million in 2Q19 comparing to THB 52.4 million in 2Q18 or a surge of 39% . Statement of Financial
. Tambon Tarsit, Amohoe Pluag-daeng, Rayong As of June 30, 2018 the Company and its subsidiary had a significant surge in trade and other receivables when compared to last year which was mainly from an
policy and market opportunity meet, was launched today. It was created by the Securities Exchange Commission of Thailand [SEC] and UNDP Thailand using UNDP SDG Impact’s robust methodology, with the support
heteroscedasticity-robust standard errors. ***, ** and * = Statistical significance at the 1%, 5% and 10% level, respectively. CRT and the decision to take a complex tax incentive (Dep. variable = Opted for complex
competitiveness, and (2) fundamental issues regarding building reliability and resilience of the Thai capital market and robust foundation to support sustainable growth.” The SEC Strategic Plan 2021-2023
1. 1 percent even though the overall economic condition has continued improving from preceding year according to rapid export growth and continued robust growth in tourism. However, private
robust operational performance across all our assets. The on-going structural changes in the PET industry created opportunity for well-managed and committed producers to align supply reliability and